SFV HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

FDA Grant to Fund Simulations Plus Research

Lancaster drug simulation company Simulations Plus has won a $1.2 million grant from the U.S. Food and Drug Administration to test the efficacy of oral cavity products.

Preview: Health Care Special Report

Valley hospitals were required to spend in preparation for a surge of COVID patients that didn’t materials.

A2 Biotherapeutics Raises Nearly $72 Million in Series B

A2 Biotherapeutics in Agoura Hills closed its Series B round of financing at $71.5 million.

L.A. County to Reopen Indoor Malls, Nail Salons

The L.A. County Department of Public Health announced Thursday it will revise its rules to allow nail salons and shopping malls to resume indoor operations with limited capacity.

Arcutis Plans Secondary Offering, Private Placement

Arcutis Biotherapeutics Inc. has made a secondary offering with 4 million shares of its stock.

West Hills Hospital Appoints Chief Medical Officer

West Hills Hospital on Tuesday announced Dr. Donald David as its new chief medical officer.

Tease photo

Social Impact Fund Invests in ConsejoSano

North Hollywood health care software company ConsejoSano has received an investment from the Bernard J. Tyson Impact Fund.

Amgen, Eli Lilly to Manufacture COVID-19 Treatments

Biopharma giants Amgen Inc. and Eli Lilly on Thursday announced an antibody manufacturing collaboration for potential COVID-19 treatments.

Amgen Selects Bay Area Startups for Big Ticket Program

Amgen Inc. on Tuesday announced its Golden Ticket winners — startup companies BigHat Biosciences and Trilo Therapeutics.

West Hills Hospital Closes Obstetrics Unit After 'Significant Decline' in Births

West Hills Hospital will close its obstetrics program effective Nov. 1, the organization announced earlier this month.

FDA Approves Atara Biotherapeutics to Begin Tumor Trial

Atara Biotherapeutics has received the U.S. Food and Drug Administration’s green light to start clinical trials for its next-generation CAR T therapy.

Amgen to Join Dow Jones Industrial Index

Amgen Inc. will join the Dow Jones Industrial Index on Aug. 31, according to S&P Dow Jones Indices.

Tease photo

FDA Approves Eyenuk System for Retinal Scanning

Medical device company Eyenuk Inc. announced U.S. Food and Drug Administration clearance to market its diabetic retinopathy detection software.

Cure Pharmaceutical to Buy Sera Labs for $20 Million

Cure Pharmaceutical on Tuesday announced it will acquire privately held Sera Labs in Sherman Oaks for $20 million.

Amgen Grows Revenue in Pandemic

Amgen Inc. beat analyst expectations during the second quarter, despite the effects of the coronavirus on the health care industry.

Prev